MedPath

Effect of Total Sleep Deprivation on Vascular Function

Not Applicable
Completed
Conditions
Sleep Deprivation
Interventions
Other: Exercise
Other: Supervised Total Sleep Deprivation
Registration Number
NCT04535219
Lead Sponsor
University of Florida
Brief Summary

Insufficient sleep is associated with an increased risk for cardiovascular disease. The causal mechanisms are currently unknown, but may include endothelial dysfunction. The purpose of this study is to examine the influence of sex and aging on the effects of total sleep deprivation on vascular function and whether exercise training attenuates these effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Group CSupervised Total Sleep DeprivationParticipants will have vascular function assessed following total sleep deprivation preceded by exercise
Group ASupervised Total Sleep DeprivationParticipants will have vascular function assessed following total sleep deprivation
Group CExerciseParticipants will have vascular function assessed following total sleep deprivation preceded by exercise
Primary Outcome Measures
NameTimeMethod
Endothelial functionthrough study completion, an average of 1 month

Endothelial function will be determined using brachial artery flow-mediated dilation via high resolution duplex ultrasonography. Reactive hyperemia will be produced by inflating a forearm cuff to \~250 mmHg for 5 minutes followed by rapid deflation.

Microvascular functionthrough study completion, an average of 1 month

Microvascular function will be assessed using the forearm blood flow response to submaximal handgrip exercise. Brachial artery blood flow and diameter will be assessed using Doppler ultrasound.

Secondary Outcome Measures
NameTimeMethod
Central arterial stiffnessthrough study completion, an average of 1 month

The SphygmoCor XCEL device will be used to measure carotid to femoral pulse wave velocity.

Central arterial hemodynamicsthrough study completion, an average of 1 month

The SphygmoCor XCEL device will be used to obtain central pulse wave analysis.

Trial Locations

Locations (1)

University of Florida

🇺🇸

Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath